ZKB/PUT/BAYER/28/0.05/06.01.25 | Market Closed - Swiss Exchange 11:20:00 2024-07-11 am EDT | ||
| 0.15 CHF | -11.76% |
|
| 1 month | +15.38% | ||
| 3 months | -6.25% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
BAYER AG
| Date | Price | Change |
|---|---|---|
| 24-07-11 | 0.15 | -11.76% |
| 24-07-10 | 0.17 | -5.56% |
| 24-07-09 | 0.18 | +5.88% |
Delayed Quote Swiss Exchange
Last update July 11, 2024 at 11:20 am EDT
More quotesStatic data
| Product type | Plain-Vanilla-Warrants |
|---|---|
| Buy / Sell | PUT |
| Underlying | BAYER AG |
| Issuer | ZKB |
| BAY47Z | |
| ISIN | CH1305134483 |
| Date issued | 2024-01-31 |
| Strike | 28 € |
| Maturity | 2025-01-06 (179 Days) |
| Parity | 20 : 1 |
| Emission price | 0.16 CHF |
| Emission volume | N/A |
| Settlement | cash |
| Currency | CHF |
Technical Indicators
| Highest since issue | 0.19 CHF |
|---|---|
| Lowest since issue | 0.1 CHF |
| Spread | 0.01 CHF |
| Spread % | 6.67% |
Company Profile
Bayer AG is one of the world's leaders in designing, producing, and marketing pharmaceutical products and agrochemicals. Net sales are distributed by product family as follows:
- agrochemicals (48.8%): herbicides, fungicides, insecticides, etc.;
- pharmaceutical products (38%): intended for the prevention and treatment of cardiovascular and respiratory diseases, diabetes, nervous system disorders, etc.;
- OTC products and nutritional supplements (12.7%);
- other (0.5%).
Net sales are distributed geographically as follows: Germany (5.1%), Switzerland (1.2%), Europe-Middle East-Africa (23.2%), the United States (30.6%), North America (3.5%), China (7.6%), Asia-Pacific (10%), Brazil (10.4%) and Latin America (8.4%).
Sector
-
Consensus: Bayer AG
Sell
Buy
Mean consensus
HOLD
Number of Analysts
22
Last Close Price
26.64
EUR
Average target price
36.14
EUR
Spread / Average Target
+35.65%
- Stock Market
- Warrants
- BAY47Z Warrant
